High Tide Executives to Spotlight Global Strategy at Major Cannabis and Investor Conferences
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from High Tide ( (TSE:HITI) ) is now available.
High Tide Inc., a Canadian cannabis retailer and distributor behind the Canna Cabana chain and German-based Remexian Pharma, has built a diversified, retail-forward platform spanning brick-and-mortar stores, international e-commerce and medical cannabis distribution. The company holds a significant share of the Canadian retail market, has expanded into Germany with a physical presence and medical imports, and has been repeatedly acknowledged for rapid growth in both Canadian and broader American rankings.
The company announced that its senior executives will speak at several high-profile cannabis and investor conferences across North America and Europe in the coming months. Appearances in Berlin, New York, London and Las Vegas will cover topics such as German cannabis reforms, international investment opportunities, advocacy, European M&A and consumer trends, underscoring High Tide’s efforts to raise its global profile, influence policy discussions and engage investors as it deepens its international footprint.
The most recent analyst rating on (TSE:HITI) stock is a Buy with a C$7.00 price target. To see the full list of analyst forecasts on High Tide stock, see the TSE:HITI Stock Forecast page.
Spark’s Take on HITI Stock
According to Spark, TipRanks’ AI Analyst, HITI is a Neutral.
The score is held back primarily by weak financial quality (persistent losses and elevated leverage) and bearish technicals (price below major moving averages with negative MACD). Offsetting these, cash flow has improved meaningfully and the latest earnings call was constructive with stronger adjusted EBITDA/free-cash-flow trends and clear growth initiatives, but valuation remains relatively expensive given current profitability.
To see Spark’s full report on HITI stock, click here.
More about High Tide
High Tide Inc. is a Canadian community-grown, retail-forward cannabis enterprise with fully integrated operations spanning retail and medical cannabis distribution. Through its Canna Cabana chain, the company operates 220 stores in Canada and one international location, and also runs global e-commerce platforms for cannabis accessories and hemp-derived CBD products.
Canna Cabana is the largest cannabis retail chain in Canada, with outlets across British Columbia, Alberta, Saskatchewan, Manitoba and Ontario and a growing 12% domestic market share, and it pioneered the cannabis discount club model in 2021. High Tide also owns Remexian Pharma in Germany, a major importer and wholesaler of medical cannabis licensed to source from 19 countries, and has been repeatedly recognized as one of Canada’s top-growing and fastest-growing retail companies.
YTD Price Performance: -11.99%
Average Trading Volume: 74,945
Technical Sentiment Signal: Sell
Current Market Cap: C$283.9M
See more insights into HITI stock on TipRanks’ Stock Analysis page.
